Document Type

Article

Publication Title

Case reports in hematology

Abstract

Myeloproliferative disorders are variable disorders, based on the genetic abnormality present and the cell line progenitors that are affected. In this case, we discuss a novel gene translocation in the subset of PDGFRB mutations, first seen with prominent hyperbasophilia. This case demonstrates the possibility for lower therapeutic doses of imatinib mesylate than previously reported, in order to control leukocyte counts and reverse the genetic mutation.

First Page

709164

Last Page

709164

DOI

10.1155/2013/709164

Publication Date

1-1-2013

Download

Included in

Oncology Commons

Share

COinS